A

Aptorum Group Limited
D

APM

1.65500
USD
-0.70
(-29.57%)
مغلق
حجم التداول
66,616
الربح لكل سهم
1
العائد الربحي
-
P/E
-5
حجم السوق
11,822,918
الأخبار المقالات

العنوان: Aptorum Group Limited

القطاع: Healthcare
الصناعة: Biotechnology
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.